Its lead product candidate includes injectable meloxicam, which completed pivotal phase III clinical trials for the treatment of post-operative pain. Further Reading: Most Active Stocks Want to see …
More Recro Pharma Inc (NASDAQ:REPH) Shares Acquired by BlackRock Inc. Videos